A single intramuscular injection with an adenovirus-expressing IL-12 protects BALB/c mice against Leishmania major infection, while treatment with an IL-4-expressing vector increases disease susceptibility in B10.D2 mice.
J Immunol
; 162(2): 753-60, 1999 Jan 15.
Article
in En
| MEDLINE
| ID: mdl-9916695
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Vaccines, Synthetic
/
Adenoviridae
/
Interleukin-4
/
Leishmaniasis, Cutaneous
/
Leishmania major
/
Interleukin-12
/
Genetic Vectors
Limits:
Animals
Language:
En
Journal:
J Immunol
Year:
1999
Document type:
Article
Affiliation country:
United States
Country of publication:
United States